The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions

International Journal of Oral and Maxillofacial Surgery

Volumn 38, Issue 11, 2009, Pages 1188-1193

  Vladimirov, B S ^a   Schiodt, M ^b  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

oral potentially malignant lesions; quitting smoking; recurrence; surgical excision

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROPLASIA; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LEUKOPLAKIA; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK REDUCTION; SMOKING CESSATION; SMOKING HABIT; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ERYTHROPLASIA; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SMOKING CESSATION;

EID: 71249087575     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2009.06.026     Document Type: Article

References (25)

1. Axell T., Pindborg J.J., Smith C.J., and van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25 (1996) 49-54
2. Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 5 (1977) 69-75
3. Banoczy J., Gintner Z., and Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 65 (2001) 322-327
4. Bundgaard T. Oral cancer. Epidemiologi og prognose. Doctoral thesis, University Hospital Aarhus, 1996: 19.
5. Chandu A., and Smith A.C. The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg 34 (2005) 396-400
6. Chiesa F., Boracchi P., Tradati N., Rossi N., Costa L., Giardini R., Marazza M., and Zurrida S. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Eur J Cancer B Oral Oncol 29B (1993) 23-28
7. Cowan C.G., Gregg T.A., Napier S.S., McKenna S.M., and Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis 7 (2001) 18-24
8. Gupta P.C. A study of dose-response relationship between tobacco habits and oral leukoplakia. Br J Cancer 50 (1984) 527-531
9. Gupta P.C., Bhonsle R.B., Murti P.R., Daftary D.K., Mehta F.S., and Pindborg J.J. An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 63 (1989) 2247-2252
10. Gupta P.C., Mehta F.S., Daftary D.K., Pindborg J.J., Bhonsle R.B., Jalnawalla P.N., Sinor P.N., Pitkar V.K., Murti P.R., Irani R.R., Shah H.T., Kadam P.M., Iyer K.S., Iyer H.M., Hedge A.K., Chandrashekar G.K., Shiroff B.C., Sahiar B.E., and Mehta M.N. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 8 (1980) 283-333
11. Gupta P.C., Murti P.R., Bhonsle R.B., Mehta F.S., and Pindborg J.J. Effect of cessation of tobacco use on the incidence of oral mucosal lesions in a 10-yr follow-up study of 12,212 users. Oral Dis 1 (1995) 54-58
12. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42 (2006) 461-474
13. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Oral premalignant lesions: is a biopsy reliable?. J Oral Pathol Med 36 (2007) 262-266
14. Jaber M.A., Porter S.R., Gilthorpe M.S., Bedi R., and Scully C. Risk factors for oral epithelial dysplasia - the role of smoking and alcohol. Oral Oncol 35 (1999) 151-156
15. Martin G.C., Brown J.P., Eifler C.W., and Houston G.D. Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc 130 (1999) 945-954
16. Poate T.W., and Warnakulasuriya S. Effective management of smoking in an oral dysplasia clinic in London. Oral Dis 12 (2006) 22-26
17. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14 (2003) 47-62
18. Reichart P.A. Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Investig 5 (2001) 207-213
19. Reichart P.A., and Philipsen H.P. Oral erythroplakia - a review. Oral Oncol 41 (2005) 551-561
20. Roed-Petersen B. Effect on oral leukoplakia of reducing or ceasing tobacco smoking. Acta Derm Venereol 62 (1982) 164-167
21. Saito T., Sugiura C., Hirai A., Notani K., Totsuka Y., Shindoh M., Kohgo T., and Fukuda H. High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis 5 (1999) 15-19
22. Schepman K.P., van der Meij E.H., Smeele L.E., and van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from the Netherlands. Oral Oncol 34 (1998) 270-275
23. Shiu M.N., Chen T.H., Chang S.H., and Hahn L.J. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 82 (2000) 1871-1874
24. Silverman Jr. S., Gorsky M., and Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53 (1984) 563-568
25. Tradati N., Grigolat R., Calabrese L., Costa L., Giugliano G., Morelli F., Scully C., Boyle P., and Chiesa F. Oral leukoplakias: to treat or not?. Oral Oncol 33 (1997) 317-321